Clinical Trials Logo

Clinical Trial Summary

In this single center prospective cohort study a total of 100 patients scheduled for elective off-pump CABG will be recruited. They will be allocated to one study and one control group according to the presence or absence of postoperative type 2 neurological complications. The two groups will be compared in terms of serum concentrations of glial fibrillary acidic protein (GFAP), neuroserpin (NSP), phosphorylated axonal neurofilament subunit H (pNfH) and visinin-like protein 1 (VILIP-1) at the time of skin incision and closure as well as 24 hours and 7 days following surgery. Diagnostic performance of these markers for predicting type 2 neurological complications of off-pump CABG will be assessed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Neurological Complication of Procedure (Disorder)

NCT number NCT03493256
Study type Observational
Source Collegium Medicum w Bydgoszczy
Contact
Status Completed
Phase
Start date April 1, 2018
Completion date March 1, 2019